Queen's University

Overview

The PhD in Pathology and Molecular Medicine at Queen's University offers an in-depth exploration of the mechanisms of disease through the lens of molecular biology. This program emphasizes research in key areas such as cancer biology, genetics, hemostasis, and vascular biology, all supported by expert faculty research groups. Students engage in hands-on training in a collaborative environment, preparing them for a successful career in research and academia.

What you'll study

Doctoral training integrates graduate coursework with a significant research project. Selected courses may vary depending on individual backgrounds and supervisor requirements. Key components of the curriculum include:

• Animal Care

• Research Ethics Education: Gateway to CHRPP

• Experimental Cancer Therapeutics

• Cancer Biology

• The Molecular Basis of Disease

• Research Project in Pathology (core doctoral research component)

• Bioinformatics for Cancer Research

Research component: Throughout the program, students will undertake a research project that aligns with their supervisor’s expertise and their dissertation objectives, culminating in a comprehensive doctoral thesis.

Professional development: PhD candidates are expected to adhere to research ethics and responsible conduct guidelines while progressing through the program's milestones, as outlined by the department.

Entry requirements

Applicants are required to hold a relevant academic background, typically reflected in their GPA. It is advisable for prospective students to review faculty research interests and establish contact with potential supervisors to discuss available research positions. Standard application materials usually include academic transcripts, a curriculum vitae, a research statement, and proof of English language proficiency.

Career prospects

Graduates of the Pathology and Molecular Medicine PhD program are well-prepared for a variety of roles in research, academia, and industry. Alumni often pursue careers in medical research, healthcare, biotechnology, and pharmaceuticals, contributing to advancements in understanding and treating complex diseases.